Ixazomib -Daratumumab Without Dexamethasone (IDara) in Elderly Relapse Refractory Multiple Myeloma

Clinical trial NCT03757221 · TERMINATED

Trial details

NCT number: NCT03757221
Sponsor: University Hospital, Caen
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2019-02-07
Primary completion: 2022-09-15
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.